Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve This is to inform ....
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HealthCare Global Enterprises (HCG) has informed the stock exchanges that a Board of Directors meeting is scheduled for Wednesday, November 12, 2025, at the company's corporate office in Bengaluru. The Board will, among other things, consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and six months ended September 30, 2025, i.e., Q2 and H1 of FY26. As per insider trading rules, the trading window for designated persons has been closed since October 1, 2025, and will remain closed until 48 hours after the results are declared.
This is a routine regulatory intimation and does not by itself move the stock. Investors should mark November 12, 2025 on their calendar as the date when HCG's Q2 and H1 FY26 earnings will be announced, which is the next material catalyst for the stock.